Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D Bromberg

Showing results (111-120 of 124) with videos related to

Pageof 13
Sort By:
Molecular and Cellular Biology|September 17, 2005
JAMP, a Jun N-terminal kinase 1 (JNK1)-associated membrane protein, regulates duration of JNK activityTakayuki Kadoya, Ashwani Khurana, Marianna Tcherpakov, et al.
Clinical Epigenetics|July 28, 2022
Distinct modulation of IFNγ-induced transcription by BET bromodomain and catalytic P300/CBP inhibition in breast cancerSimon J Hogg, Olga Motorna, Conor J Kearney, et al.
ACS Medicinal Chemistry Letters|May 31, 2021
Discovery of a Potent and Selective Covalent p300/CBP InhibitorAnthony Mastracchio, Chunqiu Lai, Enrico Digiammarino, et al.
ACS Medicinal Chemistry Letters|January 16, 2015
Pyrimidine-based tricyclic molecules as potent and orally efficacious inhibitors of wee1 kinaseYunsong Tong, Maricel Torrent, Alan S Florjancic, et al.
Cell|May 29, 2018
Time-Resolved Analysis Reveals Rapid Dynamics and Broad Scope of the CBP/p300 AcetylomeBrian T Weinert, Takeo Narita, Shankha Satpathy, et al.
Plos One|February 14, 2008
The ER-bound RING finger protein 5 (RNF5/RMA1) causes degenerative myopathy in transgenic mice and is deregulated in inclusion body myositisAgnès Delaunay, Kenneth D Bromberg, Yukiko Hayashi, et al.
Bioorganic & Medicinal Chemistry Letters|February 25, 2021
Discovery of spirohydantoins as selective, orally bioavailable inhibitors of p300/CBP histone acetyltransferasesZhiqin Ji, Richard F Clark, Vikram Bhat, et al.
ACS Medicinal Chemistry Letters|January 20, 2018
Discovery of Spiro Oxazolidinediones as Selective, Orally Bioavailable Inhibitors of p300/CBP Histone AcetyltransferasesMichael R Michaelides, Arthur Kluge, Michael Patane, et al.
Journal of Medicinal Chemistry|October 1, 2024
Discovery of Potent Azetidine-Benzoxazole MerTK Inhibitors with <i>In Vivo</i> Target EngagementRobin R Frey, Navendu Jana, Jacob V Gorman, et al.
Nature Chemical Biology|January 24, 2017
The SUV4-20 inhibitor A-196 verifies a role for epigenetics in genomic integrityKenneth D Bromberg, Taylor R H Mitchell, Anup K Upadhyay, et al.
Pageof 13

Showing results (111-120 of 124) with videos related to

Sort By:
Pageof 13
Molecular and Cellular Biology|September 17, 2005
JAMP, a Jun N-terminal kinase 1 (JNK1)-associated membrane protein, regulates duration of JNK activityTakayuki Kadoya, Ashwani Khurana, Marianna Tcherpakov, et al.
Clinical Epigenetics|July 28, 2022
Distinct modulation of IFNγ-induced transcription by BET bromodomain and catalytic P300/CBP inhibition in breast cancerSimon J Hogg, Olga Motorna, Conor J Kearney, et al.
ACS Medicinal Chemistry Letters|May 31, 2021
Discovery of a Potent and Selective Covalent p300/CBP InhibitorAnthony Mastracchio, Chunqiu Lai, Enrico Digiammarino, et al.
ACS Medicinal Chemistry Letters|January 16, 2015
Pyrimidine-based tricyclic molecules as potent and orally efficacious inhibitors of wee1 kinaseYunsong Tong, Maricel Torrent, Alan S Florjancic, et al.
Cell|May 29, 2018
Time-Resolved Analysis Reveals Rapid Dynamics and Broad Scope of the CBP/p300 AcetylomeBrian T Weinert, Takeo Narita, Shankha Satpathy, et al.
Plos One|February 14, 2008
The ER-bound RING finger protein 5 (RNF5/RMA1) causes degenerative myopathy in transgenic mice and is deregulated in inclusion body myositisAgnès Delaunay, Kenneth D Bromberg, Yukiko Hayashi, et al.
Bioorganic & Medicinal Chemistry Letters|February 25, 2021
Discovery of spirohydantoins as selective, orally bioavailable inhibitors of p300/CBP histone acetyltransferasesZhiqin Ji, Richard F Clark, Vikram Bhat, et al.
ACS Medicinal Chemistry Letters|January 20, 2018
Discovery of Spiro Oxazolidinediones as Selective, Orally Bioavailable Inhibitors of p300/CBP Histone AcetyltransferasesMichael R Michaelides, Arthur Kluge, Michael Patane, et al.
Journal of Medicinal Chemistry|October 1, 2024
Discovery of Potent Azetidine-Benzoxazole MerTK Inhibitors with <i>In Vivo</i> Target EngagementRobin R Frey, Navendu Jana, Jacob V Gorman, et al.
Nature Chemical Biology|January 24, 2017
The SUV4-20 inhibitor A-196 verifies a role for epigenetics in genomic integrityKenneth D Bromberg, Taylor R H Mitchell, Anup K Upadhyay, et al.
Pageof 13